Literature DB >> 8415765

The segment of invariant chain that is critical for association with major histocompatibility complex class II molecules contains the sequence of a peptide eluted from class II polypeptides.

I M Freisewinkel1, K Schenck, N Koch.   

Abstract

Major histocompatibility complex class II molecules present peptides from an extracellular source of antigens to CD4+ T lymphocytes. The class II-associated invariant chain affects this role of alpha and beta polypeptides by restriction of peptide loading to endocytic vesicles. Up to now no specific portion of the invariant chain has been defined as the class II binding site. We constructed recombinant invariant chain genes and inspected association of the mutant invariant chains with class II polypeptides. Here we demonstrate that an extracytoplasmic sequence of the invariant chain (aa 81-109) that is only 23 residues away from the transmembrane region is essential for contact with class II polypeptides, whereas the remaining C-terminal part is dispensable for binding. The sequence of invariant-chain-derived peptides that were eluted from class II molecules is contained in this segment and may define the class II binding site of the invariant chain. The membrane-proximal position of this region suggests that the invariant chain and invariant-chain-derived peptides isolated from class II molecules bind to a domain distinct from the class II pocket.

Mesh:

Substances:

Year:  1993        PMID: 8415765      PMCID: PMC47638          DOI: 10.1073/pnas.90.20.9703

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  Truncation variants of peptides isolated from MHC class II molecules suggest sequence motifs.

Authors:  P Preston-Hurlburt; B K al-Ramadi; J Rothbard; C A Janeway
Journal:  Nature       Date:  1992-10-01       Impact factor: 49.962

2.  Transformation of mammalian cells with genes from procaryotes and eucaryotes.

Authors:  M Wigler; R Sweet; G K Sim; B Wold; A Pellicer; E Lacy; T Maniatis; S Silverstein; R Axel
Journal:  Cell       Date:  1979-04       Impact factor: 41.582

3.  Differential expression of HLA-DR, -DQ, and -DP antigens on malignant B cells.

Authors:  J M Pesando; L Graf
Journal:  J Immunol       Date:  1986-06-01       Impact factor: 5.422

4.  cDNA clone for the human invariant gamma chain of class II histocompatibility antigens and its implications for the protein structure.

Authors:  L Claesson; D Larhammar; L Rask; P A Peterson
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

5.  Monoclonal anti-Ia murine alloantibodies crossreactive with the Ia-homologues of other mammalian species including humans.

Authors:  M Watanabe; T Suzuki; M Taniguchi; N Shinohara
Journal:  Transplantation       Date:  1983-12       Impact factor: 4.939

6.  Invariant chain associates with HLA class II antigens via its extracytoplasmic region.

Authors:  M S Marks; P Cresswell
Journal:  J Immunol       Date:  1986-04-01       Impact factor: 5.422

7.  Murine class II (Ia) molecules associate with human invariant chain.

Authors:  L H Glimcher; B S Polla; A Poljak; C C Morton; D J McKean
Journal:  J Immunol       Date:  1987-03-01       Impact factor: 5.422

8.  Monoclonal antibodies detect polymorphic determinants shared by I-A and I-E antigens.

Authors:  N Koch; M S Sandrin; G J Hämmerling; N Tada; S Kimura; U Hämmerling
Journal:  Mol Immunol       Date:  1984-04       Impact factor: 4.407

9.  Structure of the murine Ia-associated invariant (Ii) chain as deduced from a cDNA clone.

Authors:  P A Singer; W Lauer; Z Dembić; W E Mayer; J Lipp; N Koch; G Hämmerling; J Klein; B Dobberstein
Journal:  EMBO J       Date:  1984-04       Impact factor: 11.598

10.  Signal recognition particle-dependent membrane insertion of mouse invariant chain: a membrane-spanning protein with a cytoplasmically exposed amino terminus.

Authors:  J Lipp; B Dobberstein
Journal:  J Cell Biol       Date:  1986-06       Impact factor: 10.539

View more
  29 in total

1.  Introducing endogenous antigens into the major histocompatibility complex (MHC) class II presentation pathway. Both Ii mediated inhibition and enhancement of endogenous peptide/MHC class II presentation require the same Ii domains.

Authors:  K Frauwirth; N Shastri
Journal:  Immunology       Date:  2001-04       Impact factor: 7.397

Review 2.  HLA-DM and the MHC class II antigen presentation pathway.

Authors:  P E Jensen; D A Weber; W P Thayer; X Chen; C T Dao
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

3.  Specific treatment of autoimmunity with recombinant invariant chains in which CLIP is replaced by self-epitopes.

Authors:  F Bischof; W Wienhold; C Wirblich; G Malcherek; O Zevering; A M Kruisbeek; A Melms
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-02       Impact factor: 11.205

4.  Glycoprotein B from strain 17 of herpes simplex virus type I contains an invariant chain homologous sequence that binds to MHC class II molecules.

Authors:  Elisabeth Sievers; Jürgen Neumann; Martin Raftery; Günther SchOnrich; Anna Maria Eis-Hübinger; Norbert Koch
Journal:  Immunology       Date:  2002-09       Impact factor: 7.397

5.  Granulocyte-macrophage colony-stimulating factor elevates invariant chain expression in immature myelomonocytic cell lines.

Authors:  I Klagge; U Kopp; N Koch
Journal:  Immunology       Date:  1997-05       Impact factor: 7.397

Review 6.  MHC class II antigen presentation by dendritic cells regulated through endosomal sorting.

Authors:  Toine ten Broeke; Richard Wubbolts; Willem Stoorvogel
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-12-01       Impact factor: 10.005

7.  Structure of a trimeric domain of the MHC class II-associated chaperonin and targeting protein Ii.

Authors:  A Jasanoff; G Wagner; D C Wiley
Journal:  EMBO J       Date:  1998-12-01       Impact factor: 11.598

8.  Efficient loading of HLA-DR with a T helper epitope by genetic exchange of CLIP.

Authors:  J van Bergen; S P Schoenberger; F Verreck; R Amons; R Offringa; F Koning
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

9.  Interaction of MHC class II molecules with the invariant chain: role of the invariant chain (81-90) region.

Authors:  P Stumptner; P Benaroch
Journal:  EMBO J       Date:  1997-10-01       Impact factor: 11.598

10.  Direct observation of disordered regions in the major histocompatibility complex class II-associated invariant chain.

Authors:  A Jasanoff; S J Park; D C Wiley
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.